Preetha Chengot

Preetha Chengot

Auto-generated profile, based on publicly available information

Preetha Chengot

Leeds Teaching Hospitals NHS Trust, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
SSSchaida Schirwani
Schaida Schirwani
SFSheila Fraser
Sheila Fraser
TMTalat Mushtaq
Talat Mushtaq
PCPreetha Chengot
Preetha Chengot
LMLampros A. Mavrogiannis
Lampros A. Mavrogiannis
JAJulian Adlard
Julian Adlard

1 April 2018 in British Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Open access
Anastasios KanatasAnastasios Kanatas
Anastasios Kanatas
PCP. Chengot
P. Chengot
TOT.K. Ong
T.K. Ong
MHM.W. Ho
M.W. Ho
NSN. Sethi
N. Sethi
HWHenry M Wood
Henry M Wood
We studied the progression from dysplasia to invasive carcinoma and subsequent second primaries or locoregional recurrences in 11 patients with recurrent squamous cell carcinoma (SCC). Between one and six samples were sequenced/patient. DNA samples were prepared, and libraries multiplexed to between 40 and 80 samples/lane of an Illumina HiSeq 3000 and sequenced with 2×100bp paired end sequencing. Copy number data were generated by CNAnorm (Bioconductor package). Samples of recurrent SCC showed unique patterns of descent when compared with earlier samples from the primary tumour, and three main patterns emerged. In four patients there was convincing evidence that the later lesion was descended directly from cells from the first, and in a further four there were no detectable genomic events between the two lesions. Three patients had some shared events between the early and later lesions, but although there were enough differences to deduce that the two lesions had a shared ancestor, they were not directly descended from each other. We present the patients' characteristics in detail, including the overall survival in each group. There was a distinct genomic pattern after a second episode of SCC in all the groups. A larger study that uses similar methods and a longer duration could provide reliable conclusions with respect to survival. With the use of new techniques, genomic data can be available to clinical teams during the planning of treatment.


21 February 2022 in Clinical Imaging
Verified
Journal Article
Closed access
EWEdward Walker
Edward Walker
SKShishir Karthik
Shishir Karthik
PCPreetha Chengot
Preetha Chengot
SVSriram Vaidyanathan
Sriram Vaidyanathan

1 October 2018 in Diagnostic Histopathology
Verified
Journal Article
Closed access
AWAlice C. Pathology Nick Westwood
Alice C. Pathology Nick Westwood
PCPreetha Chengot
Preetha Chengot

1 January 2023 in The Annals of The Royal College of Surgeons of England
Verified
Journal Article
Open access
WKW Kendall
W Kendall
PCP Chengot
P Chengot
TMT Munir
T Munir
JMJw Moor
Jw Moor
Langerhans’ cell histiocytosis (LCH) is a rare condition characterised by histiocyte proliferation leading to destructive granulomatous lesions. It may occur anywhere in the body but extraosseous manifestations affecting the head and neck are particularly uncommon. Here, we present the first reported case of a mass arising in the retropharyngeal space caused by LCH. The patient was a 33-year-old man with various symptoms which are presented. Although rare, LCH can affect a variety of tissues in the head and neck. Clinicians need to be cognisant of its inclusion in the differential diagnoses for similar cases in their practice, in particular because of potential difficulties in diagnosis.